Macrophage phagocytosis and killing.

DD Dominik Deniffel
BN Brian Nuyen
KP Kwang Pak
KS Keigo Suzukawa
JH Jun Hung
AK Arwa Kurabi
SW Stephen I. Wasserman
AR Allen F. Ryan
request Request a Protocol
ask Ask a question
Favorite

Macrophage phagocytosis and bacterial killing were assessed by using an established in vitro assay (13, 14). Primary peritoneal macrophages were obtained from 6 ccl3−/− and 6 WT mice as described previously (13, 14) and seeded into 48-well plates at 5 × 105 cells per well in triplicate for each mouse and assay time point. Ten microliters of mid-exponential-phase NTHi bacteria (5 × 107 bacteria), a titer that does not saturate the cells, as demonstrated previously (13), was added to each well. After incubation for 1 h, extracellular bacteria were removed and killed by washing, followed by the addition of fresh Dulbecco's modified Eagle medium (DMEM) containing 10% fetal calf serum (FCS), macrophage colony-stimulating factor, and 50 μg/ml gentamicin. After the addition of gentamicin, incubation was continued for 1 or 3 h. The cells were then rinsed and lysed. Supernatants and cell lysates were plated onto chocolate agar in serial dilutions, incubated overnight at 37°C, and then evaluated by manually counting CFU. Six wells were used per time point and mouse strain. The recovery of bacteria after macrophage treatment with gentamicin for 1 h was used to represent phagocytosis. The ratio of the number of NTHi bacteria recovered after gentamicin treatment for 3 h compared to the number of bacteria recovered at 1 h posttreatment was considered to represent intracellular killing (14, 22). Percent bacterial killing was calculated as previously described (22), by using the following formula: % killing = 1 − (number of CFU in tested wells 3 h after cultivation with gentamicin/number of CFU in tested wells 1 h after cultivation) × 100.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A